Atypical Meningiomas: Histologic and Clinical Factors Associated With Recurrence
- PMID: 30684705
- DOI: 10.1016/j.wneu.2019.01.056
Atypical Meningiomas: Histologic and Clinical Factors Associated With Recurrence
Abstract
Background: Atypical meningioma is a heterogeneous group of tumors with an unpredictable behavior. Our objectives were to study patients with atypical meningioma, monitor their follow-up, identify the histologic characteristics, and analyze factors associated with severe outcomes.
Methods: This retrospective study involved 28 patients with atypical meningioma from 1994 to 2014. The histologic samples were reviewed under current criteria. The association with recurrence and survival was analyzed statistically for clinical, therapeutic, histologic, and molecular factors.
Results: The average age at the time of diagnosis was 55.5 years (range, 18-83 years) and 57% were female. Total resection (Simpson grade I) was performed in 10 cases (38%). Adjuvant radiotherapy was given to 13 patients. During the 77-month follow-up, 64% had a recurrence or progression. The average time to first recurrence and overall survival were 43.83 months and 149 months, respectively. Recurrence was found in 85% of the patients whose samples presented necrosis. Of the tumors, 84% showed a high mitotic index (4-20 mitoses/10 high-power field). Of the 4 patients with a low mitotic index (<4 mitoses/10 high-power field), the degree of resection was subtotal and 3 experienced disease progression. Of patients with Ki67 >9.9%, 67% had recurrence. The degree of resection was the only variable significantly associated with tumor recurrence.
Conclusions: The high rate of recurrence observed and the short disease-free survival exemplify the unpredictable behavior of atypical meningiomas. Total resection was the only significant factor associated with recurrence. However, the presence of atypical features, such as necrosis or high Ki67, is frequent in patients with disease progression.
Keywords: Atypical meningioma; Predictive factor; Prognosis; Tumor recurrence.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.Acta Neurochir (Wien). 2014 Aug;156(8):1475-81. doi: 10.1007/s00701-014-2156-z. Epub 2014 Jun 26. Acta Neurochir (Wien). 2014. PMID: 24965072
-
Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.J Neurooncol. 2020 Jan;146(2):347-355. doi: 10.1007/s11060-019-03382-x. Epub 2020 Jan 3. J Neurooncol. 2020. PMID: 31900826
-
Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.Cancer Med. 2019 Jan;8(1):13-20. doi: 10.1002/cam4.1531. Cancer Med. 2019. PMID: 30680963 Free PMC article.
-
Long-term surgical outcomes of spinal meningiomas.Spine (Phila Pa 1976). 2012 May 1;37(10):E617-23. doi: 10.1097/BRS.0b013e31824167f1. Spine (Phila Pa 1976). 2012. PMID: 22146282 Review.
-
Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.World Neurosurg. 2018 Apr;112:e74-e83. doi: 10.1016/j.wneu.2017.12.035. Epub 2017 Dec 16. World Neurosurg. 2018. PMID: 29258946 Review.
Cited by
-
Diagnostic nomogram model for predicting preoperative pathological grade of meningioma.Transl Cancer Res. 2021 Sep;10(9):4057-4064. doi: 10.21037/tcr-21-798. Transl Cancer Res. 2021. PMID: 35116703 Free PMC article.
-
An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas.Radiat Oncol. 2022 Aug 22;17(1):147. doi: 10.1186/s13014-022-02090-7. Radiat Oncol. 2022. PMID: 35996160 Free PMC article.
-
Impact on natural history of atypical meningioma after changes in 2016 edition of the world health organization (WHO) classification of central nervous system tumors: a literature review.Neurosurg Rev. 2024 Sep 28;47(1):704. doi: 10.1007/s10143-024-02881-4. Neurosurg Rev. 2024. PMID: 39340638 Review.
-
Somatostatin Receptor Theranostics for Refractory Meningiomas.Curr Oncol. 2022 Aug 4;29(8):5550-5565. doi: 10.3390/curroncol29080438. Curr Oncol. 2022. PMID: 36005176 Free PMC article.
-
Lateral Ventricular Meningiomas: Clinical Features, Radiological Findings and Long-Term Outcomes.Cancer Manag Res. 2021 Aug 4;13:6089-6099. doi: 10.2147/CMAR.S320651. eCollection 2021. Cancer Manag Res. 2021. PMID: 34377027 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources